FDA experts report changes in drug approvals, warnings, and indications for products for use by dermatologists and aesthetic medicine professionals.

Clinical characteristics, such as comorbidities or patient behaviors, vary by racial/ethnic group and sex in patients with ...

From 2016 to 2022, parents in the United States have not substantially changed their behavior regarding infant sleeping ...

The US FDA has approved Vtama 1% cream for the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 ...

Better control of risk factors and proper use of medications, besides having other health-related benefits, will also help ...

Percentage of annual ED visits with an influenza test ordered or provided increased from 2.5 to 10.9 percent. HealthDay News ...

Interim analysis shows that the antiviral is safe but has no effect on pain among adults with mild-to-moderate clade II mpox.

The US DOJ has filed a civil complaint against CVS Pharmacy Inc., accusing the chain of unlawfully filling prescriptions for ...

Life expectancy in the United States increased in 2023, reaching 78.4 years, while drug overdose mortality decreased from ...

The US FDA wants to redefine the meaning of healthy food, changing the way food companies can claim their products are indeed ...

The use of risankizumab after poor response to 2 interleukin-17 inhibitors, secukinumab, and ixekizumab, was safe and effective in plaque psoriasis.

Long-term treatment with guselkumab is associated with sustained improvements in joint/skin symptoms and disease activity among patients with active PsA.